Immunotherapeutic strategies for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-11-01 / Gastroenterology 2004 Nov;127(5 Suppl 1):S232-41Immunobiology and gene-based immunotherapy of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-10Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells
/in Hepatocellular Carcinoma, International Publications /von 2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-402A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
/in Hepatocellular Carcinoma, International Publications /von 2003-02-06 / Cancer Immunol. Immunother. 2003 Mar;52(3):155-61Effective treatment of small murine hepatocellular carcinoma by dendritic cells
/in Hepatocellular Carcinoma, International Publications /von 2001-11-01 / Hepatology 2001 Nov;34(5):896-905
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives